Current Studies

Trailblazer
Alzheimer’s

AVP
Alzheimer’s

APOLLOE4
Alzheimer’s

PrecMed
Parkinson’s

PrecMed
Alzheimer’s

PrecMed
Multiple Sclerosis

SOSTOS
Multiple Sclerosis

Trailblazer Alzheimer's Study - Healthy Volunteers

The Trailblazer Alzheimer’s Study involves people who have normal memory, thinking, mood and behavior patterns. Participants are randomly assigned to one of two groups. They receive either the investigational drug or a placebo. Those who receive placebo may have the option to receive the investigational drug at a later time.

This study might be right for you if you are:

AVP Alzheimer’s Study - The ASPECT Study

The ASPECT Study will look at an investigational medication for people with Alzheimer’s Disease. The purpose of this study is to evaluate the safety and effectiveness of an investigational drug for agitation associated with Alzheimer’s Dementia.

This study might be right for you if you are:

APOLLOE4 Alzheimer’s Study - The APOLLO Study

Our team of medical professionals is evaluating an investigational drug that is designed to slow the progression of Alzheimer’s Disease. The study drug, ALZ-801, is a tablet that is taken twice daily. It has been well tolerated in earlier studies and may be a convenient option for Alzheimer’s patients and their families. Participating in this study, will help advance the treatment of Alzheimer’s disease.

This study might be right for you if you are:

CuraSen - Alzheimer's and Parkinson's Study

This research study is evaluating an investigational drug combination, CST-2032 combined with CST-107 (nadolol), as a possible treatment for cognitive impairment due to Alzheimer’s disease (AD) or Parkinson’s disease (PD) with rapid eye movement (REM) sleep behavior disorder. CuraSen Therapeutics, Inc. is sponsoring this research study.

This study might be right for you if you are:

Alzheimer's Disease - The SKYLINE Study

Alzheimer’s is linked to the build-up of an abnormal protein in the brain called amyloid beta. Early on, this process doesn’t cause any obvious symptoms. But later, cognitive problems such as memory loss may emerge. The question is, could targeting amyloid beta prevent this?

This study might be right for you if you are:

Novartis - Multiple Sclerosis and Covid Study

f you are between the ages of 18 and 55 and have been diagnosed with relapsing multiple sclerosis
(MS), you may quality for a voluntary research study.

This study might be right for you if you are:

Multiple Sclerosis - The ENSURE Study

The purpose of the ENSURE Study is to investigate how safe and effective the study drug is in helping treat people with Relapsing Multiple Sclerosis by reducing relapses.

This study might be right for you if you are:

Parkinson's Disease - The ORCHESTRA Study

The Orchestra Study is a clinical research study for people with early-stage Parkinson’s disease. The aim of the study is to see whether the investigational medication known as UCB0599 can slow Parkinson’s disease progression.

This study might be right for you if you are:

PrecMed Parkinson’s Study

The purpose of this medical study is to collect biological samples from subjects with Parkinson’s disease. The samples may contain substances that the researchers will be able to analyze to study their genetic, protein, and chemical composition. The study will look at blood and cerebrospinal fluid differences associated with Parkinson’s disease or with other aspects of the illness, such as response to medication and side effects. The cells from your blood may be retained as cell lines grown from your blood to be used in the future. The sample may assist in the development of a new drug treatment or a new diagnostic test for Parkinson’s disease. Your samples will be kept indefinitely by the sponsor.

PrecMed Alzheimer’s Study

The purpose of this medical study is to collect biological samples from subjects with Alzheimer’s disease. The samples may contain substances that the researchers will be able to analyze to study their genetic, protein, and chemical composition. The study will look at blood and cerebrospinal fluid differences associated with Alzheimer’s disease or with other aspects of the illness, such as response to medication and side effects. The cells from your blood may be retained as cell lines grown from your blood to be used in the future. The sample may assist in the development of a new drug treatment or a new diagnostic test for Alzheimer’s disease. Your samples will be kept indefinitely by the sponsor.

PrecMed Multiple Sclerosis Study

The purpose of this medical study is to collect biological samples from subjects with Multiple Sclerosis. The samples may contain substances that the researchers will be able to analyze to study their genetic, protein, and chemical composition. The study will look at blood and cerebrospinal fluid differences associated with Multiple Sclerosis or with other aspects of the illness, such as response to medication and side effects. The cells from your blood may be retained as cell lines grown from your blood to be used in the future. The sample may assist in the development of a new drug treatment or a new diagnostic test for Multiple Sclerosis. Your samples will be kept indefinitely by the sponsor.

The SOSTOS Multiple Sclerosis Study

The purpose of this study is to find out if patients who have not had a relapse in the past year would benefit from switching to ofatumumab compared to continuing their current MS treatment. This study will also find out if having an elevated Neurofilament light (NfL) level can predict a greater benefit from switching to ofatumumab compared to continuing current treatment. NfL is a biomarker that may be an indicator of damage in a wide variety of neurological disorders.